Sacubitril/valsartan ameliorates cardiac hypertrophy and preserves diastolic function in cardiac pressure overload

AIMS: Sacubitril/valsartan (sac/val) has shown superior effect compared with blockade of the renin–angiotensin–aldosterone system in heart failure with reduced ejection fraction. We aimed to investigate effects of sac/val compared with valsartan in a pressure overload model of heart failure with pre...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:ESC Heart Fail
Autori principali: Nordén, Einar Sjaastad, Bendiksen, Bård Andre, Andresen, Henriette, Bergo, Kaja Knudsen, Espe, Emil Knut, Hasic, Almira, Hauge‐Iversen, Ida Marie, Veras, Ioanni, Hussain, Rizwan I., Sjaastad, Ivar, Christensen, Geir, Cataliotti, Alessandro
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2021
Soggetti:
Original Research Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8006657/
https://ncbi.nlm.nih.gov/pubmed/33497525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13177
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi